Financials Globe Life Inc.

Equities

GL

US37959E1029

Life & Health Insurance

Real-time Estimate Cboe BZX 19:38:08 18/07/2024 BST 5-day change 1st Jan Change
89.45 USD +0.58% Intraday chart for Globe Life Inc. +5.03% -26.45%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 11,397 9,939 9,464 11,726 11,456 8,007 - -
Enterprise Value (EV) 1 13,045 11,862 11,490 13,803 13,572 10,737 11,215 11,714
P/E ratio 15.4 x 13.9 x 13 x 16.1 x 12.1 x 7.71 x 6.95 x 6.31 x
Yield 0.66% 0.79% 0.84% 0.69% 0.74% 1.07% 1.14% 1.22%
Capitalization / Revenue 2.52 x 2.1 x 1.85 x 2.25 x 2.1 x 1.37 x 1.31 x 1.26 x
EV / Revenue 2.88 x 2.5 x 2.25 x 2.65 x 2.49 x 1.84 x 1.84 x 1.84 x
EV / EBITDA 12.6 x 11.9 x 11.3 x - - 7.19 x 7.42 x 7.48 x
EV / FCF - - - - - - 22,429,720 x -
FCF Yield - - - - - - 0% -
Price to Book 1.59 x 1.14 x 1.09 x 2.43 x 2.58 x 1.46 x 1.24 x 1.05 x
Nbr of stocks (in thousands) 108,288 104,662 100,979 97,270 94,119 90,042 - -
Reference price 2 105.2 94.96 93.72 120.6 121.7 88.93 88.93 88.93
Announcement Date 04/02/20 02/02/21 02/02/22 01/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,528 4,738 5,113 5,215 5,448 5,827 6,095 6,366
EBITDA 1 1,032 1,000 1,016 - - 1,493 1,511 1,567
EBIT 1 - 706.7 666.3 799.4 1,279 1,388 1,452 1,682
Operating Margin - 14.92% 13.03% 15.33% 23.47% 23.82% 23.82% 26.42%
Earnings before Tax (EBT) 1 - - - - 1,194 1,328 1,443 1,539
Net income 1 760.8 731.8 745 739.7 970.8 1,079 1,148 1,218
Net margin 16.8% 15.45% 14.57% 14.18% 17.82% 18.51% 18.84% 19.14%
EPS 2 6.830 6.820 7.220 7.470 10.07 11.53 12.80 14.09
Free Cash Flow - - - - - - 500 -
FCF margin - - - - - - 8.2% -
FCF Conversion (EBITDA) - - - - - - 33.09% -
FCF Conversion (Net income) - - - - - - 43.54% -
Dividend per Share 2 0.6900 0.7500 0.7900 0.8300 0.9000 0.9530 1.012 1.081
Announcement Date 04/02/20 02/02/21 02/02/22 01/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,297 1,308 1,293 1,291 1,323 1,321 1,326 1,384 1,416 1,416 1,450 1,466 1,482 1,506 1,521
EBITDA - - - - - - - - - - - - - - -
EBIT 1 159.4 159.3 206 215.8 218.4 311 315.4 324.3 327.8 324.4 346.3 351.1 352.8 340.2 347.8
Operating Margin 12.29% 12.17% 15.93% 16.71% 16.51% 23.54% 23.78% 23.43% 23.16% 22.9% 23.88% 23.94% 23.81% 22.59% 22.87%
Earnings before Tax (EBT) 1 217.6 201.6 217 230 257.7 274.2 264.5 318.8 336.7 314.9 341.3 346.9 351.7 352.2 356.4
Net income 1 178 164.4 177 186.8 211.6 223.6 215.3 257.1 274.8 254.2 272 274.6 278.6 281.4 289.8
Net margin 13.72% 12.56% 13.69% 14.46% 15.99% 16.92% 16.23% 18.57% 19.41% 17.95% 18.76% 18.73% 18.8% 18.69% 19.05%
EPS 2 1.760 1.640 1.790 1.900 2.140 2.280 2.240 2.680 2.880 2.670 2.880 2.958 3.029 3.070 3.207
Dividend per Share 2 0.1975 0.2075 0.2075 0.2075 0.2075 0.2250 0.2250 0.2250 0.2250 - 0.2400 0.2400 0.2400 - -
Announcement Date 02/02/22 20/04/22 27/07/22 26/10/22 01/02/23 03/05/23 26/07/23 25/10/23 07/02/24 22/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,648 1,923 2,026 2,077 2,116 2,729 3,207 3,707
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.597 x 1.922 x 1.994 x - - 1.828 x 2.123 x 2.366 x
Free Cash Flow - - - - - - 500 -
ROE (net income / shareholders' equity) 11.6% 9.5% 8.13% 10.9% 24.3% 21.8% 19.2% 17.3%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 66.00 83.20 86.00 49.70 47.10 60.70 71.60 85.00
Cash Flow per Share - 13.80 13.90 14.40 - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 04/02/20 02/02/21 02/02/22 01/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
88.93 USD
Average target price
104.1 USD
Spread / Average Target
+17.07%
Consensus
  1. Stock Market
  2. Equities
  3. GL Stock
  4. Financials Globe Life Inc.